Initial observations of Jinhua Qinggan Granules, a Chinese medicine, in the mitigation of hospitalization and mortality in high-risk elderly with COVID-19 infection: A retrospective study in an old age home in Hong Kong
- PMID: 35966846
- PMCID: PMC9363753
- DOI: 10.3389/fmed.2022.948149
Initial observations of Jinhua Qinggan Granules, a Chinese medicine, in the mitigation of hospitalization and mortality in high-risk elderly with COVID-19 infection: A retrospective study in an old age home in Hong Kong
Keywords: COVID-19; Chinese medicine; Jinhua Qinggan Granules (JHQG); Omicron; SARS-CoV-2.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Effect of Jinhua Qinggan granules on novel coronavirus pneumonia in patients.J Tradit Chin Med. 2020 Jun;40(3):467-472. doi: 10.19852/j.cnki.jtcm.2020.03.016. J Tradit Chin Med. 2020. PMID: 32506862
-
Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial.Front Med (Lausanne). 2022 Aug 1;9:928468. doi: 10.3389/fmed.2022.928468. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35979216 Free PMC article.
-
Efficacy of Jinhua Qinggan Granules Combined With Western Medicine in the Treatment of Confirmed and Suspected COVID-19: A Randomized Controlled Trial.Front Med (Lausanne). 2021 Oct 12;8:728055. doi: 10.3389/fmed.2021.728055. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34712679 Free PMC article.
-
Potential of herbal products in prevention and treatment of COVID-19. Literature review.Biomed Pharmacother. 2021 Nov;143:112150. doi: 10.1016/j.biopha.2021.112150. Epub 2021 Sep 2. Biomed Pharmacother. 2021. PMID: 34507112 Free PMC article. Review.
-
Combating COVID-19 with integrated traditional Chinese and Western medicine in China.Acta Pharm Sin B. 2020 Jul;10(7):1149-1162. doi: 10.1016/j.apsb.2020.06.009. Epub 2020 Jun 27. Acta Pharm Sin B. 2020. PMID: 32834946 Free PMC article. Review.
Cited by
-
Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19.Front Med. 2023 Dec;17(6):1014-1029. doi: 10.1007/s11684-023-1040-8. Epub 2023 Dec 29. Front Med. 2023. PMID: 38157191 Review.
-
Herbal medicine in the treatment of COVID-19 based on the gut-lung axis.Acupunct Herb Med. 2022 Sep;2(3):172-183. doi: 10.1097/HM9.0000000000000038. Epub 2022 Dec 8. Acupunct Herb Med. 2022. PMID: 37808350 Free PMC article. Review.
References
-
- Hong Kong now has the world's highest Covid-19 death rate . What happened, and how can this be fixed? (2022). Available online at: https://www.scmp.com/news/hong-kong/health-environment/article/3169331/h... (accessed May 02, 2022).
-
- Kim L, Garg S, O'Halloran A, Whitaker M, Pham H, Anderson EJ, et al. . Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019(COVID-19)-associated hospitalization surveillance network (COVID-NET). Clin Infect Dis. (2021) 72:e206–14. 10.1093/cid/ciaa1012 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous